Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

The Effect of AI-Assisted Nursing Process Training on Nursing Process Competence, Perception and Attitudes Towards Artificial Intelligence in Nurses: A Randomized Controlled Study

24 maj 2026 uppdaterad av: Seher Dağlı, University of Yalova

Hemşirelerde Yapay Zeka Destekli Hemşirelik Süreci Eğitiminin Hemşirelik Süreci Yetkinliğine, Yapay Zeka Algı ve Tutumuna Etkisi: Randomize Kontrollü Bir Çalışma

This study aims to determine how applied artificial intelligence (AI) training affects nurses' ability to manage the nursing process and their perceptions and attitudes toward AI technology

  • The nursing process is a scientific, six-stage approach used by nurses to identify patient needs and provide holistic care

The research is a randomized controlled trial involving 78 nurses at Yalova Education and Research Hospital

. Participants will be split into two groups: Both groups will receive standard theoretical training on the nursing process

. The intervention group will receive additional specialized training on using AI tools (such as ChatGPT and Deepseek) to help create nursing care plans through practical case studies

. Nurses' skills and views will be measured using specific scales before the training and one month after the intervention to evaluate the training's effectiveness

  • This study is expected to provide valuable insights into how AI can support clinical decision-making and help healthcare providers adapt to new technologies
  • The research has been approved by the Yalova University Ethics Committee (Protocol 2026/183) and will be conducted between May and December 2026

Studieöversikt

Detaljerad beskrivning

This randomized controlled, quasi-experimental study is designed to evaluate the impact of an applied artificial intelligence (AI)-supported nursing process training program on nurses' professional competence and their attitudes toward AI technology. The primary objective is to determine how the integration of AI tools into clinical decision-making affects nursing process efficiency and perception among healthcare professionals

. Methodology and Randomization: The study population consists of 414 nurses working at Yalova Education and Research Hospital

  • Based on power analysis (power=0.95, alpha=0.05), a total of 78 nurses will be recruited and randomized into two groups: an intervention group (n=39) and a control group (n=39)
  • Randomization will be conducted following the collection of baseline (pre-test) data

Intervention Protocol:

Phase 1 (Common Foundation): Both the intervention and control groups will receive a "Theoretical Training on the Nursing Process" to ensure baseline knowledge standardization . Phase 2 (AI Training - Intervention Group only): The intervention group will receive "AI-Supported Nursing Process Theoretical Training," which includes technical guidance on using AI tools (such as ChatGPT and Deepseek) for clinical care

,

. Phase 3 (Practical Application - Intervention Group only): Participants will engage in hands-on workshops using structured clinical cases. They will apply AI tools to generate care plans based on NANDA-I, NIC, and NOC taxonomies

  • This phase includes structured debriefing and feedback sessions led by the researcher

The control group will only receive the standard theoretical nursing process education and will not have access to the AI training modules until the study is completed .

Data Collection and Assessment: Data will be collected using three instruments:

The Nurse Information Form (demographics and AI usage habits) . The Nursing Process Competence Scale (to measure clinical workflow skills)

. The Artificial Intelligence Perception and Attitude Scale (YAZAT-24) (to measure attitudes toward AI integration)

,

. Measurements will be conducted at two time points: baseline (pre-test) and one month following the intervention (post-test) to assess long-term retention and impact

,

. Statistical Analysis: Data analysis will be performed using SPSS 22.0. Normality will be assessed via the Kolmogorov-Smirnov test. Analysis will include descriptive statistics, independent samples t-test or Mann-Whitney U for group comparisons, and Repeated Measures ANOVA or Friedman tests for within-group changes over time

Studietyp

Interventionell

Inskrivning (Beräknad)

78

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studera Kontakt Backup

Studieorter

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Vuxen
  • Äldre vuxen

Tar emot friska volontärer

Ja

Beskrivning

Inclusion Criteria:

  • Volunteering to participate in the study.
  • Working actively as a nurse in the specified institution (Yalova Training and Research Hospital).
  • Not having previously used artificial intelligence in the nursing process.

Exclusion Criteria:

  • Refusing to participate in the study.
  • Having previously used artificial intelligence in the nursing process. Submitting incomplete data collection forms.
  • Requesting to withdraw from the study.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Hälsovårdsforskning
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Intervention Group
Participants will receive a standard theoretical education session on the nursing process. Following this, they will receive an applied artificial intelligence-supported nursing process training and engage in case study practices using AI tools.
Participants will receive theoretical education on the artificial intelligence-supported nursing process and engage in applied case studies using AI tools in small groups.
Participants will receive a standard theoretical education session on the nursing process.
Aktiv komparator: Control Group
Participants will receive only the standard theoretical education session on the nursing process. They will not receive the artificial intelligence-supported training or case study practices during the study period.
Participants will receive a standard theoretical education session on the nursing process.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Change in Nursing Process Competence
Tidsram: Baseline (pre-test) and 1 month after the intervention (post-test)
This outcome is measured using the Nursing Process Competence Scale. The scale consists of 24 items and 5 sub-dimensions evaluated on a 5-point Likert scale. The average score ranges from 1 to 5, and higher scores indicate higher nursing process competence
Baseline (pre-test) and 1 month after the intervention (post-test)

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Change in Artificial Intelligence Perception and Attitude
Tidsram: Baseline (pre-test) and 1 month after the intervention (post-test).
This outcome is measured using the Artificial Intelligence Perception and Attitude Scale (YAZAT-24). The scale consists of 24 items and 4 sub-dimensions evaluated on a 7-point Likert scale. Higher total scores indicate more positive perceptions and attitudes towards artificial intelligence.
Baseline (pre-test) and 1 month after the intervention (post-test).

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Beräknad)

1 juni 2026

Primärt slutförande (Beräknad)

31 december 2026

Avslutad studie (Beräknad)

31 december 2026

Studieregistreringsdatum

Först inskickad

24 maj 2026

Först inskickad som uppfyllde QC-kriterierna

24 maj 2026

Första postat (Faktisk)

1 juni 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

1 juni 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

24 maj 2026

Senast verifierad

1 maj 2026

Mer information

Termer relaterade till denna studie

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • 2026/183

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera